Physician profile
Samir Kumar Ahuja
NPI 1679778658
$5,417.46
in general payments reported to CMS, 2019-2025
37 companies · $1,356 in 2025
The $1,356 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $748 · 2020: $196 · 2021: $426 · 2022: $491 · 2023: $879 · 2024: $1,322 · 2025: $1,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,556.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,294.75 | 2019-2025 | Jot Dx, Confirm Rx, Aveir |
| Actelion Pharmaceuticals US, INC. | $591.35 | 2019-2023 | Opsumit |
| Amgen INC. | $443.84 | 2019-2025 | Repatha, Repatha |
| Novo Nordisk INC | $363.69 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $261.24 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $252.11 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $217.57 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $164.30 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $148.79 | 2020-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $147.31 | 2022-2025 | Symplicity G3 |
| Welch Allyn | $147.00 | 2021 | |
| Kestra Medical Technology Services, INC. | $125.90 | 2025 | Assure Wcd |
| Kiniksa Pharmaceuticals, LTD. | $122.44 | 2022-2023 | Arcalyst |
| Merck Sharp & Dohme LLC | $121.78 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $116.80 | 2022-2025 | Watchman Flx, Watchman |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $115.67 | 2024 | Injectafer |
| Inspire Medical Systems, INC. | $95.98 | 2024-2025 | Inspire |
| Janssen Pharmaceuticals, INC | $91.55 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.67 | 2022-2024 | |
| Lexicon Pharmaceuticals, INC. | $69.35 | 2023-2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $55.56 | 2019-2024 | |
| Atricure, INC. | $51.06 | 2022-2023 | |
| Silk Road Medical, INC. | $43.18 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Scpharmaceuticals INC. | $34.60 | 2023-2024 | |
| Alnylam Pharmaceuticals INC. | $27.97 | 2025 | Amvuttra |
| Lundbeck LLC | $24.53 | 2019 | |
| Abiomed | $23.81 | 2024 | Impella |
| Biotronik INC. | $23.34 | 2019 | |
| Amarin Pharma, INC. | $22.03 | 2022 | |
| Portola Pharmaceuticals, LLC | $21.75 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $20.99 | 2024 | Arcalyst |
| Heartflow, INC. | $18.91 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $16.75 | 2019 | |
| Tactile Systems Technology INC | $13.97 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.85 | 2022 | |
| Cleerly, INC. | $13.15 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Medtronic Vascular, INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Ahuja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.